Latest Insider Transactions at Quest Diagnostics Inc (DGX)
This section provides a real-time view of insider transactions for Quest Diagnostics Inc (DGX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of QUEST DIAGNOSTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of QUEST DIAGNOSTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
7,947
-14.11%
|
$1,033,110
$130.09 P/Share
|
|
Mar 07
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
16,162
+22.29%
|
$2,101,060
$130.09 P/Share
|
|
Mar 07
2022
|
Mark Guinan Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,475
-9.57%
|
$1,361,750
$130.09 P/Share
|
|
Mar 07
2022
|
Mark Guinan Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,780
+15.96%
|
$2,701,400
$130.09 P/Share
|
|
Mar 07
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,316
-10.47%
|
$691,080
$130.09 P/Share
|
|
Mar 07
2022
|
Michael E Prevoznik SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,544
+18.53%
|
$1,500,720
$130.09 P/Share
|
|
Mar 07
2022
|
Stephen H Rusckowski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
32,570
-8.86%
|
$4,234,100
$130.09 P/Share
|
|
Mar 07
2022
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,184
+16.04%
|
$9,123,920
$130.09 P/Share
|
|
Mar 07
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-1.4%
|
$118,820
$130.09 P/Share
|
|
Mar 07
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,516
+3.62%
|
$327,080
$130.09 P/Share
|
|
Feb 28
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
661
-1.66%
|
$85,930
$130.0 P/Share
|
|
Feb 24
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
11,745
+13.55%
|
-
|
|
Feb 24
2022
|
Michael E Prevoznik SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,741
+6.43%
|
-
|
|
Feb 24
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
1,669
-4.3%
|
$210,294
$126.26 P/Share
|
|
Feb 24
2022
|
Mark Guinan Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,251
+2.48%
|
-
|
|
Feb 24
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,681
+5.66%
|
-
|
|
Feb 24
2022
|
J. E. Davis CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
9,787
+14.59%
|
-
|
|
Feb 24
2022
|
Catherine T. Doherty EVP, Regional Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
3,328
+4.68%
|
-
|
|
Feb 24
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
2,750
-4.1%
|
$346,500
$126.26 P/Share
|
|
Feb 24
2022
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,510
+7.04%
|
-
|
|
Feb 23
2022
|
Manner Carrie Eglinton SVP, Advanced Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-3.31%
|
$257,010
$130.16 P/Share
|
|
Feb 23
2022
|
J. E. Davis CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,436
-2.47%
|
$316,680
$130.16 P/Share
|
|
Feb 23
2022
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
1,574
-1.15%
|
$204,620
$130.16 P/Share
|
|
Feb 23
2022
|
Mark Guinan Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,367
-1.34%
|
$307,710
$130.16 P/Share
|
|
Feb 23
2022
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-0.58%
|
$40,690
$130.16 P/Share
|
|
Feb 23
2022
|
Michael E Prevoznik SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.68%
|
$174,070
$130.16 P/Share
|
|
Feb 23
2022
|
Stephen H Rusckowski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,718
-1.72%
|
$1,263,340
$130.16 P/Share
|
|
Nov 29
2021
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
37,565
-8.06%
|
$5,822,575
$155.66 P/Share
|
|
Nov 29
2021
|
Catherine T. Doherty EVP, Regional Businesses |
BUY
Exercise of conversion of derivative security
|
Direct |
37,565
+26.11%
|
$3,568,675
$95.8 P/Share
|
|
Aug 16
2021
|
Tracey Doi Director |
BUY
Grant, award, or other acquisition
|
Direct |
905
+50.0%
|
-
|
|
Jul 29
2021
|
Stephen H Rusckowski Director |
SELL
Open market or private sale
|
Direct |
9,493
-1.64%
|
$1,329,020
$140.9 P/Share
|
|
Jul 29
2021
|
Stephen H Rusckowski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,493
+1.61%
|
$901,835
$95.8 P/Share
|
|
Jul 28
2021
|
Stephen H Rusckowski Director |
SELL
Open market or private sale
|
Direct |
139,751
-32.95%
|
$19,565,140
$140.14 P/Share
|
|
Jul 28
2021
|
Stephen H Rusckowski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
139,751
+24.78%
|
$13,276,345
$95.8 P/Share
|
|
Jul 27
2021
|
Gail R Wilensky Director |
SELL
Open market or private sale
|
Direct |
12,222
-25.51%
|
$1,698,858
$139.3 P/Share
|
|
Jul 27
2021
|
Gail R Wilensky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,222
+20.32%
|
$721,098
$59.4 P/Share
|
|
Jul 27
2021
|
Stephen H Rusckowski Director |
SELL
Open market or private sale
|
Direct |
32,788
-10.34%
|
$4,590,320
$140.01 P/Share
|
|
Jul 27
2021
|
Stephen H Rusckowski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,788
+9.37%
|
$3,114,860
$95.8 P/Share
|
|
Jul 26
2021
|
Stephen H Rusckowski Director |
SELL
Open market or private sale
|
Direct |
5,813
-2.0%
|
$813,820
$140.03 P/Share
|
|
Jul 26
2021
|
Stephen H Rusckowski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,813
+1.96%
|
$552,235
$95.8 P/Share
|
|
May 25
2021
|
Denise M Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+20.75%
|
-
|
|
May 25
2021
|
Helen Torley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+17.88%
|
-
|
|
May 25
2021
|
Timothy L Main Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+6.11%
|
-
|
|
May 25
2021
|
Wright Lassiter Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+29.35%
|
-
|
|
May 25
2021
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+7.1%
|
-
|
|
May 25
2021
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+5.78%
|
-
|
|
May 25
2021
|
Gary M Pfeiffer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+5.53%
|
-
|
|
May 21
2021
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+8.13%
|
-
|
|
May 18
2021
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.02%
|
$680
$136.6 P/Share
|
|
May 07
2021
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
8,536
-11.05%
|
$1,186,504
$139.96 P/Share
|